Back to search
FDAFDA · Food and drugs·Recall number D-0236-2017

Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10

Published January 4, 2017 · Recall initiated: December 22, 2016

Summary

FDA records drug Class II recall D-0236-2017, published January 4, 2017 and initiated December 22, 2016. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 96 bottles; Lot: Lot GG1539. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Incorporated
Distributor
MS and OH.
Lot
Lot GG1539
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDC 0781-1182-10 recalled?

Yes. FDA published recall D-0236-2017 on January 4, 2017. Reported hazard: Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)

What should I do if I have this product?

Voluntary: Firm initiated · Letter